It sounds like a valid reason to. Misuse of medication leading to the development of drug resistance is a major issue.
It sounds like the concers were not properly addressed in a sufficient way. Andnim wondering what if potentially they didnt properly address the issues in the context of key demographic/history/culture of malaria endemic areas.
Did SUD half arse the appeal with a 'near enough is good enough' approach or are the concerns something that are actually too difficult to overvome?
Ann: ArTiMist Appeal Reasons For Decision, page-11
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $147.2M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.8¢ | 14.0¢ | $264.0K | 1.835M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 717964 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 336380 | 4 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| ALA (ASX) Chart |